P1360: CLINICAL TRANSLATION OF A NOVEL, POTENT AND WELL-CHARACTERIZED INDUCED REGULATORY T-CELL PRODUCT AGAINST GRAFT VERSUS HOST DISEASE
Memnon Lysandrou(University of Patras), Alexandros Spyridonidis(General University Hospital of Patras), Elisavet Vlachonikola(Aristotle University of Thessaloniki), Panayiota Christofi(University of Patras), Paul Costeas(Deakin University), Anastasia Chatzidimitriou(Karolinska Institutet), Maria Kyriakou(Center for the Study of Childhood and Adolescence), Chryso Pieridou(Center for the Study of Childhood and Adolescence), Dionysia Kefala(University of Patras), Alexandra Lydia Chatzidaniil(G. Papanikolaou General Hospital), Evangelia Yannaki(G. Papanikolaou General Hospital), Penelope Georgia Papagianni(University of Patras), Αναστασία Παπαδοπούλου(G. Papanikolaou General Hospital), Antonis Mingos(Centre for Research and Technology Hellas), Nikolaos Savvopoulos(University of Patras)
Cited by 1
Related Papers
Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family
|Journal of Bacteriology|1992|586
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
|Leukemia|2015|258
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
|Bone Marrow Transplantation|2020|202